Syra Health Q2 revenue $2.0M (+101% YoY); net loss widens to $1.4M

Syra Health Corp

2024-Q2 EPS reported -$0.43 vs consensus -$0.19 ▼ miss (-121.9%)

Revenue $2.0M vs $1.0M in Q2 2023; Population Health grew 276% YoY, Healthcare Workforce 66%.
Gross margin improved to 17.8% from 13.1% on mix shift toward higher-margin population health.
Net loss of $1.4M compared to $802.8K loss in Q2 2023; Adjusted EBITDA -$1.3M vs -$771K.
Cash $1.6M and no long-term debt; 25% reduction in executive pay implemented starting Q3 2024.
Subcontractor on $43B DHA workforce contract vehicle; $5.8M Indiana health education contract.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.